Post on 29-Dec-2015
transcript
S. Pondell, Aug, 2008Integrated BioTech Solutions
Steve PondellDirector of Manufacturing, Encysive
PharmaceuticalsPrincipal, Integrated BioTech Solutions
August 8, 2008
Bio-Manufacturing Practices
Short Course in Biotechnology
S. Pondell, Aug, 2008Integrated BioTech Solutions
Part 1: Biotech Regulatory Environment
S. Pondell, Aug, 2008Integrated BioTech Solutions
What is Biotechnology?
► Webster’s definition: The manipulation (as through genetic
engineering) of living organisms or their components to produce useful usually commercial products (as pest resistant crops, new bacterial strains, or novel pharmaceuticals); also: any various applications of biological science used in such manipulation
S. Pondell, Aug, 2008Integrated BioTech Solutions
What is Biotechnology?
► Contemporary Examples: Genetically-engineered drugs Genetically-engineered crops Small to medium size life science
companies Alternative fuels Organisms for environmental control Nanotechnology related to health care Medical devices
S. Pondell, Aug, 2008Integrated BioTech Solutions
Regulatory Environment
► Rules, guidelines or laws formulated by a governmental agency to guide or control products in the public realm
► All companies operate in some type of regulatory environment
► Because of biotech’s potential impact to public health, it tends to be more highly regulated that other industries
S. Pondell, Aug, 2008Integrated BioTech Solutions
U.S. Biotech Regulating Bodies
► Food and Drug Administration (FDA)► Environmental Protection Agency (EPA)► Department of Agriculture► Patent and Trademark Office► Drug Enforcement Agency (DEA)
S. Pondell, Aug, 2008Integrated BioTech Solutions
Foreign Agencies
► EMEA (Europe FDA)► Therapeutic Products Division (Canada FDA)► Therapeutic Goods Administration (Australia
FDA)► Ministry of Health (Japan FDA)
S. Pondell, Aug, 2008Integrated BioTech Solutions
How Do Agencies Regulate?
► Congress passes laws Clean Water Act Food, Drug and Cosmetic Act
► Agencies create regulations Mandatory
► Agencies create guidelines Strongly suggested
► Agencies audit for compliance to regulations and guidelines
► Agencies take enforcement actions for non-compliance
S. Pondell, Aug, 2008Integrated BioTech Solutions
Dis
covery
/ S
cre
en
ing
Dis
covery
/ S
cre
en
ing
Animal Testing
Phase 2
Phase 3
Mark
eti
ng
Ap
plicati
on
M
ark
eti
ng
Ap
plicati
on
R
evie
wR
evie
w
Post-
mark
eti
ng
Post-
mark
eti
ng
Pre-Pre-clinicalclinical
ResearchResearch
Clinical Studies
Clinical ResearchClinical Research
Phase 4
IN
DIN
D
Phase 1
Development and Approval Process
S. Pondell, Aug, 2008Integrated BioTech Solutions
Typical TimelinesDiscovery to Commercial
► Alternate fuels 1 yr► Pesticide 3-5 yrs► Environmental remediator 3-5 yrs► Medical device 2-5 yrs► Small molecule drug 8-10 yrs► Biologic drug 10-12 yrs► Generic drug 2-3 yrs
S. Pondell, Aug, 2008Integrated BioTech Solutions
Compliance
► GLPs (Good Laboratory Practices) Pre-clinical, EPA
► GCPs (Good Clinical Practices) Clinical studies
► GMPs (Good Manufacturing Practices) Production and distribution of drugs and devices for
human use
► Written into Federal Register – mandatory regulations
S. Pondell, Aug, 2008Integrated BioTech Solutions
Compliance
► Guidelines Non-mandatory Provides acceptable ways to meet regulations Guidelines can become regulations
S. Pondell, Aug, 2008Integrated BioTech Solutions
Compliance
► Companies self-police Quality Unit is responsible Top management also held responsible Procedures, documentation and training
► Agencies audit on regular basis
S. Pondell, Aug, 2008Integrated BioTech Solutions
Enforcement
► Non-compliance Found during audit or review
► Official notification► Withholding of approvals► Withdrawal of product from market► Seizure of product► Legal action
Consent decree Personal liability of top management Debar
S. Pondell, Aug, 2008Integrated BioTech Solutions
Part 2: cGMP’scurrent Good Manufacturing
Practices
S. Pondell, Aug, 2008Integrated BioTech Solutions
History of FDA
In 1202, King John of England proclaimed the first English food law, which prohibited adulteration of bread with such ingredients as ground peas or beans.
In 19th century, physicians were scarce and poorly educated and many people put their faith in patent medicines, pitched by traveling salesmen as drugs and miracle cure devices.
Ingredients secret Efficacy questionable in many cases Food, Drug and Cosmetic Act of 1906 created FDA Significant revision in 1936 and again in 1960’s
S. Pondell, Aug, 2008Integrated BioTech Solutions
What are cGMP’s?
► current Good Manufacturing Practices► Developed from a series of manufacturing
mishaps in the 1960’s and 1970’s► Found in Code of Federal Regulations, Title 21,
Parts 210 and 211 (for drugs) and Part 820 (for devices)
► Applicable for drugs manufactured for human use, including investigational drugs
S. Pondell, Aug, 2008Integrated BioTech Solutions
What do cGMPs do?
► Assure the following: Identity Purity Safety Effectiveness Potency
► Of drug products► Assure that these qualities are met
Consistently Over life of product
S. Pondell, Aug, 2008Integrated BioTech Solutions
Sections of cGMP’s for Drugs
► A. General Provisions► B. Organization and Personnel► C. Buildings and Facilities► D. Equipment► E. Control of Components and Drug Product Containers
and Closures► F. Production and Process Controls► G. Packaging and Labeling Controls► H. Holding and Distribution► I. Laboratory Controls► J. Records and Reports► K. Returned and Salvaged Drug Products
S. Pondell, Aug, 2008Integrated BioTech Solutions
A. General Provisions
► Minimum requirements► Applies to drug products
Additional detail for biologically derives products Parts 600-680
Additional detail for products derived from human cells or tissue Part 1271
► Over-the-counter drugs exempted► Nutraceuticals exempted
S. Pondell, Aug, 2008Integrated BioTech Solutions
B. Organization and Personnel
► Must have “quality unit”► Must have adequate laboratories► Must have adequate personnel for task,
trained to perform task, and trained in GMP’s► Supervisors must have adequate education,
training and experience to perform task► Adequate clothing and personal hygiene so as
not to compromise product► Consultants must have adequate education,
training and experience to perform task
S. Pondell, Aug, 2008Integrated BioTech Solutions
C. Buildings and Facilities
► Adequate number and size► Good product flow so as to avoid mix-ups or
contamination► Adequate lighting, ventilation and plumbing► Adequate sewage, refuse, washing and toilet
facilities► Sanitation► Maintenance
S. Pondell, Aug, 2008Integrated BioTech Solutions
D. Equipment
► Design, size and location suitable for task► Constructed of materials that are non-reactive
with product► Maintained to avoid product contamination► Control of computer systems to assure
consistent operation► Appropriate filters to avoid product
contamination or reaction
S. Pondell, Aug, 2008Integrated BioTech Solutions
E. Control of Components and Drug Product Containers and Closures
► Components received, tested and stored to prevent contamination
► Each batch tested and approved prior to use► First in/first out► Retested periodically► Containers and closures provide appropriate
protection for product and are non-reactive
S. Pondell, Aug, 2008Integrated BioTech Solutions
F. Production and Process Controls
► Written procedures – written and followed► Approved batch record describing
manufacturing process► Calculate yields at appropriate steps► Equipment identified as to status► Product appropriately sampled and tested► Time limits on production activities► Control of microbial contamination► Reprocessing controlled
S. Pondell, Aug, 2008Integrated BioTech Solutions
G. Packaging and Labeling Controls
► Appropriate controls during receipt and storage to prevent mix-ups
► Issuance controlled, and quantities reconciled► Correct labels applied to product
Lot number, expiration date
► Tamper-evident packaging for OTC► Inspected and sampled during production► Expiry date supported by testing
S. Pondell, Aug, 2008Integrated BioTech Solutions
H. Holding and Distribution
► Warehousing Control of quarantined product prior to release Appropriate temperature and humidity controls as
needed by product
► Distribution First in/first out Traceability of lot distribution in case of recall
S. Pondell, Aug, 2008Integrated BioTech Solutions
I. Laboratory Controls
► Specifications, standards, instruments as necessary to assure identity, safety, efficacy, potency and purity of product
► All product tested and released prior to distribution
► Products routinely tested for stability► Reserve samples► Penicillin contamination avoidance
S. Pondell, Aug, 2008Integrated BioTech Solutions
J. Records and Reports
► Production and laboratory records must be maintained for life of product
► Equipment cleaning and use logs► Lot records regarding quantity, test results and
labels► Master production and control records► Batch-specific production and control records► Record review► Laboratory records► Distribution records► Complaint files
S. Pondell, Aug, 2008Integrated BioTech Solutions
K. Returned and Salvaged Drug Products
► Returned product must be held and evaluated prior to re-distribution
► Must have assurances of proper storage► Packages must be intact
S. Pondell, Aug, 2008Integrated BioTech Solutions
International Harmonization
► cGMPs exist in all major markets Europe Japan US
► International Conference on Harmonization has aligned cGMPs between major markets Interpretation can still be issue Emphasis different from market to market
S. Pondell, Aug, 2008Integrated BioTech Solutions
What is Validation?
► Definition Documented evidence that provides a high degree
of assurance that a specific process, facility, or support system will consistently produce a product meeting its predetermined specifications and quality attributes.
S. Pondell, Aug, 2008Integrated BioTech Solutions
Part of cGMP’s?
► Biologics and Pharmaceuticals – NO CFR 210/211
► Medical Devices – YES CFR 820
► BUT, FDA expects and requires validation in all cases
► Validation helps assure that products are pure, safe and effective
S. Pondell, Aug, 2008Integrated BioTech Solutions
Where did it come from?
► Originally from need to consistently control sterilization cycles for injectable solutions
► Expanded over years to include utilities and equipment
► Further expansion to processes, methods and computers
► Latest expansion has been cleaning of equipment
S. Pondell, Aug, 2008Integrated BioTech Solutions
The Parts of Validation
► Design qualification► Installation qualification► Operating qualification► Process qualification► Re-qualification
S. Pondell, Aug, 2008Integrated BioTech Solutions
What Gets Validated?
► Facilities► Utilities► Equipment► Computer Control Systems► Test Methods► Process► Cleaning► Operators?
S. Pondell, Aug, 2008Integrated BioTech Solutions
The Parts of a Qualification
► Protocol Written pre-defined acceptance criteria A description of procedures (and tests) to be
conducted, data to be collected, and methods to be utilized.
Criteria by which a successful validation will be judged
S. Pondell, Aug, 2008Integrated BioTech Solutions
The Parts of a Qualification
► Results and Report Written compilation of results Actual, traceable data Evaluation against pre-defined criteria Explanation and justification of deviations Conclusion supporting or refuting a successful
validation
S. Pondell, Aug, 2008Integrated BioTech Solutions
Part 3: Quality Assurance/
Quality Control
S. Pondell, Aug, 2008Integrated BioTech Solutions
What is Quality Assurance (QA) Quality Assurance (QA) is
the activity of providing evidence needed to establish confidence among all concerned,
that the quality-related activities are being performed effectively.
All those planned or systematic actions necessary to provide adequate confidence that a product or service will satisfy given requirements for quality.
Quality Assurance is a part and consistent pair of quality management proving fact-based external confidence to customers and other stakeholders that product meets needs, expectations, and other requirements.
QA (quality assurance) assures the existence and effectiveness of procedures that attempt to make sure - in advance - that the expected levels of quality will be reached
S. Pondell, Aug, 2008Integrated BioTech Solutions
What is Quality control (QC)?
Quality control (QC) is a procedure or set of procedures intended to
ensure that a manufactured product or performed service adheres to a defined set of quality criteria or meets the requirements of the client or customer.
Refers most commonly to a department which analyses raw materials, intermediates, and final product
S. Pondell, Aug, 2008Integrated BioTech Solutions
Role of Quality assurance in the pharmaceutical industry
Quality Assurance is a vital part of drug development in the small pharmaceutical environment. It is the department which is responsible for ensuring that all the appropriate procedures have been followed and documented so that clinical progress can be made.
Quality Assurance and Management are responsible, in FDA’s eyes, for assuring that products manufactured are safe, pure and efficacious.
S. Pondell, Aug, 2008Integrated BioTech Solutions
Types of Quality Systems
► QbD – Quality by Design► ISO 9001/14001 – More generic than cGMP’s
Apply to variety of industries
► TQM – Total Quality Management► Six Sigma
Originally developed for electronics industry (Motorola)
S. Pondell, Aug, 2008Integrated BioTech Solutions
Sigma
Sigma is a metric or mathematical/statistical term which defines how often a process fails to meet requirements.
Six Sigma is defined as a process which produces only 3.4 product defects per million opportunities (DPMO) to produce a defect.
DPMO or PPM Sigma Level
308,537 2
66,807 3
6,210 4
233 5
3.4 6
S. Pondell, Aug, 2008Integrated BioTech Solutions
A Six Sigma Process
S. Pondell, Aug, 2008Integrated BioTech Solutions
Six Sigma
A defined methodology for reducing process variation and a mathematical term for defining the number of defects produced by a process compared to the number of opportunities to create a defect.
S. Pondell, Aug, 2008Integrated BioTech Solutions
How does it work?
• Utilizes data to statistically determine where and to what extreme process variability exists.
• Step wise improvements are established to generate savings by reducing process variability.
• Focus is on: Reducing the cost to produce
▫ Reduce cycle time or downtimes
▫ Improve yields
▫ Reduce variability
▫ Manufacturing costs Customer needs
S. Pondell, Aug, 2008Integrated BioTech Solutions
DMAIC Process
Lean Six Sigma methodology utilizes a rigorous procedure called DMAIC on each input of a process and thereby controls the final output or product.
S. Pondell, Aug, 2008Integrated BioTech Solutions
Metrics
► The organization and charting of collected data to determine how well a process is performing.
► Typically each key process input is measured to determine how the actual compares to the expected. (i.e. theoretical, average, goal)
► The sequential charting of multiple data points determines the trend and variability of the process.
► Key Process Inputs and Key Process Outputs are measured.
S. Pondell, Aug, 2008Integrated BioTech Solutions
Ways to Improve Efficiency
► Decrease variability.► Decrease defects.► Decrease time span.► Process variability and defects are the prime
enemies of efficiency.► Time waste is different from material
waste in that time waste can never be salvaged.
► Process time traps must be identified and removed.
S. Pondell, Aug, 2008Integrated BioTech Solutions
Quality Control Unit
► Must have one► Approve or reject:
Components Drug product containers Closures In-process materials Packaging and labeling Final product
S. Pondell, Aug, 2008Integrated BioTech Solutions
Quality Control Unit
► Must have adequate laboratory facilities to perform testing
► Responsible for approving/rejecting all procedures and specifications
► Must have procedures, and they must be followed.
S. Pondell, Aug, 2008Integrated BioTech Solutions
Personnel Qualifications
► Must have education, training and experience to do job
► Must be trained in GMP► Training must be conducted by qualified
individuals► Training must be ongoing
S. Pondell, Aug, 2008Integrated BioTech Solutions
Personnel Qualifications
► Must be an adequate number of people to do the job
S. Pondell, Aug, 2008Integrated BioTech Solutions
Personnel Responsibilities
► Apparel appropriate to protect product from contamination
► Good sanitation and health habits► Authorized access only to limited-access areas► Those with illness or open lesions that may
affect product quality must be excluded from direct contact
S. Pondell, Aug, 2008Integrated BioTech Solutions
Consultants
► Must have education, training and experience to advise
► Records of consultants must be maintained
S. Pondell, Aug, 2008Integrated BioTech Solutions
Quality Control UnitAreas Covered Under the Quality Control Unit
1. Quality Unit2. Batch Release3. Change Management4. Deviation Management/ Failures Investigation5. Product Reviews (at lest annually: APRs)6. Product Complaints 7. Reprocess/ Rework (impact on validation and stability)8. Returns/ Salvages (assessment, investigation, disposition)9. Rejects (investigation and corrective actions)10.Stability11.Validation (status of required validation/ revalidation)12.Training/ Qualifications (related to the employee’s functions)
S. Pondell, Aug, 2008Integrated BioTech Solutions
What Happens When You Don’t Follow GMP’s?
► FDA-483► Warning Letter► Consent Decree